MedPath

Evaluation of the Fetal MPI in Abnormal Cardiotocography Cases in 3rd Trimester of Pregnancy and Fetal Outcome.

Conditions
Echocardiography
Registration Number
NCT03638245
Lead Sponsor
Ali Mohamed AbdEl-Halim Ali Mehanna
Brief Summary

The study will focus in evaluation of fetal cardiac function by using myocardial performance index in fetuses with abnormal cardiotocography in 3rd trimester.

Detailed Description

The study will focus in evaluation of fetal cardiac function by using myocardial performance index in fetuses with abnormal cardiotocography in 3rd trimester.

Study Hypothesis:

In women with non reassuring fetal cardiotocography, myocardial performance index may predict fetal distress accurately.

Study Question:

In pregnant women in the third trimester with abnormal cardiotocography, Does myocardial performance index predict fetal distress accurately?

Study Objectives:

This study aims to assess the accuracy of myocardial performance index in predicting fetal distress in pregnant women with non reassuring cardiotocography in third trimester.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
148
Inclusion Criteria
  1. Women between 30-40 weeks gestational age.
  2. Women pregnant in singleton fetus.
Exclusion Criteria
  1. Multiple pregnancies.
  2. Fetal congenital malformation.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of the Fetal Myocardial Performance Index.3rd Trimester CTG, immediately followed by Fetal Echocardiography at the same set

Evaluation of the Fetal Myocardial Performance Index in Abnormal Cardiotocography Cases in 3rd Trimester of Pregnancy and Fetal Outcome.

Secondary Outcome Measures
NameTimeMethod
Neonatal outcome observationImmediately postnatal (first five minutes after delivery)

APGAR score at the first and fifth minute

© Copyright 2025. All Rights Reserved by MedPath